Metoprolol tartrate is drug used to treat hypertension (high blood pressure). Metoprolol belongs to a class of drugs called beta blockers. This medication functions by blocking the action of certain natural chemicals in the body, such as epinephrine, on the blood vessels and heart. This effect lowers the blood pressure, strain on the heart, and heart rate. This drug is also used to treat angina (chest pain) and to improve survival after a heart attack.

Market Analysis and Insights: Global Metoprolol Tartrate Market
The global Metoprolol Tartrate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Metoprolol Tartrate Scope and Market Size
The global Metoprolol Tartrate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metoprolol Tartrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Oral
Injectable

Segment by Application
Hypertension
Cardiovascular Diseases
Others

The Metoprolol Tartrate market is analysed and market size information is provided by regions (countries). Segment by Application, the Metoprolol Tartrate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novartis
AstraZeneca
Teva Pharmaceutical Industries
Changzhou Siyao Pharmacy Limited Company
Shanghai Sine Promod Pharmaceutical
Sun Pharmaceutical Industries
ZheJiang Apeloa JiaYuan Pharmaceutical
Guangzhou Hanfangare Pharmaceutical